Clinical Trial Update: Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia

View source ↗

Summary

This trial is recruiting to investigate the role and mechanism of plasma exosome microRNAs in cognitive impairment in patients with first-episode schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Tianjin Anding Hospital | Conditions: Schizophrenia | Status: RECRUITING